{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:03:28Z","timestamp":1784347408973,"version":"3.55.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.2169\/internalmedicine.6389-25","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:08:05Z","timestamp":1765404485000},"page":"1860-1867","source":"Crossref","is-referenced-by-count":0,"title":["Fibroblast Growth Factor 23 and Osteoprotegerin in Vascular Calcification among Patients without Advanced Chronic Kidney Disease"],"prefix":"10.2169","volume":"65","author":[{"given":"Keisuke","family":"Senda","sequence":"first","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"},{"name":"Department of Cardiovascular Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Teraoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Machida","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yasukochi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aizawa Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pescatore LA, Gamarra LF, Liberman M. Multifaceted mechanisms of vascular calcification in aging. Arterioscler Thromb Vasc Biol 39: 1307-1316, 2019.","DOI":"10.1161\/ATVBAHA.118.311576"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lee SJ, Lee IK, Jeon JH. Vascular calcification - new insights into its mechanism. Int J Mol Sci 21: 2685, 2020.","DOI":"10.3390\/ijms21082685"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, Hern\u00e1ndez-Carballo C, et al. Fibroblast growth factor 23 expression in human calcified vascular tissues. Aging (Albany NY) 11: 7899-7913, 2019.","DOI":"10.18632\/aging.102297"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jimbo R, Kawakami-Mori F, Mu S, et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency. Kidney Int 85: 1103-1111, 2014.","DOI":"10.1038\/ki.2013.332"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204: 321-329, 2009.","DOI":"10.1016\/j.atherosclerosis.2008.09.033"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Schafer C, Heiss A, Schwarz A, et al. The serum protein \u03b1<sub>2<\/sub>-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003.","DOI":"10.1172\/JCI200317202"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832, 1990.","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bohn E, Tangri N, Gali B, et al. Predicting risk of mortality in dialysis patients: a retrospective cohort study evaluating the prognostic value of a simple chest X-ray. BMC Nephrol 14: 263, 2013.","DOI":"10.1186\/1471-2369-14-263"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132: 245-250, 1997.","DOI":"10.1016\/S0021-9150(97)00106-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamamoto H, Kitagawa T, Kihara Y. Clinical implications of the coronary artery calcium score in Japanese patients. J Atheroscler Thromb 21: 1101-1108, 2014.","DOI":"10.5551\/jat.26427"},{"key":"11","unstructured":"11. Leow K, Szulc P, Schousboe JT, et al. Prognostic value of abdominal aortic calcification: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 10: e017205, 2021."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kawaguchi YO, Fujimoto S, Nozaki YO, Tomizawa N, Daida H, Minamino T. Current status and future perspective of coronary artery calcium score in asymptomatic individuals. J Cardiol 85: 275-282, 2025.","DOI":"10.1016\/j.jjcc.2024.11.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watase M, Shiraishi Y, Chubachi S, et al. Coronary artery calcification on chest computed tomography as a predictor of cardiovascular adverse events in patients with COVID-19 - a multicenter retrospective study in Japan. Circ J 89: 373-381, 2025.","DOI":"10.1253\/circj.CJ-24-0661"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nakahara T, Kawai-Kowase K, Matsui H, et al. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells. Atherosclerosis 253: 102-110, 2016.","DOI":"10.1016\/j.atherosclerosis.2016.08.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408, 2011.","DOI":"10.1172\/JCI46122"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ter Maaten JM, Voors AA, Damman K, et al. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol 253: 84-90, 2018.","DOI":"10.1016\/j.ijcard.2017.10.010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rochette L, Meloux A, Rigal E, et al. The role of osteoprotegerin in vascular calcification and bone metabolism: the basis for developing new therapeutics. Calcif Tissue Int 105: 239-251, 2019.","DOI":"10.1007\/s00223-019-00573-6"},{"key":"18","unstructured":"18. Makarovi\u0107 S, Makarovi\u0107 Z, Steiner R, Mihaljevi\u0107 I, Milas-Ahi\u0107 J. Osteoprotegerin and vascular calcification: clinical and prognostic relevance. Coll Antropol 39: 461-468, 2015."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hermans MM, Brandenburg V, Ketteler M, et al.; The Netherlands cooperative study on the adequacy of Dialysis (NECOSAD). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72: 202-207, 2007.","DOI":"10.1038\/sj.ki.5002178"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hutcheson JD, Blaser MC, Aikawa E. Giving calcification its due: recognition of a diverse disease: a first attempt to standardize the field. Circ Res 120: 270-273, 2017.","DOI":"10.1161\/CIRCRESAHA.116.310060"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chen Y, Fukui M, Yamada S, Komuro I. Calcific aortic valve disease - from mechanism to therapeutic strategy. Circ J 89: 1447-1452, 2025.","DOI":"10.1253\/circj.CJ-24-0706"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Di Lullo L, Gorini A, Bellasi A, et al. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease. Clin Kidney J 8: 732-736, 2015.","DOI":"10.1093\/ckj\/sfv073"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/14\/65_6389-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:26:16Z","timestamp":1784345176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/14\/65_6389-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6389-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"6389-25"}}